Articles From: Alexandria Begins 10,000 m Drill Program in Val d'Or to Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala


2014/7/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0956856001&sourceType=1 http://media3.marketwire.com/logos/20121018-alexlogo1.jpg TORONTO, ONTARIO --
Sign-up for Alexandria Begins 10,000 m Drill Program in Val d'Or investment picks
2014/7/17
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0958063001&sourceType=1 http://media3.marketwire.com/logos/20121018-alexlogo1.jpg TORONTO, ONTARIO --
Sign-up for Alexandria Identifies New Drill Targets on Western Cadillac Break Properties investment picks
2014/8/27
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0964805001&sourceType=1 http://media3.marketwire.com/logos/20121018-alexlogo1.jpg TORONTO, ONTARIO --
Sign-up for Alexandria Minerals Announces Year-End Financial Results for Fiscal Year Ended April 30, 2014 investment picks
2014/9/5
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0966540001&sourceType=1 http://media3.marketwire.com/logos/20121018-alexlogo1.jpg TORONTO, ONTARIO --
Sign-up for Alexandria Minerals Presenting at 2014 Precious Metals Summit in Colorado investment picks
Uber Will Lease Entire 422,980 RSF Pursuant to 15-Year Lease as it Expands Corporate Headquarters in San Francisco PASADENA, Calif.
Sign-up for Alexandria Real Estate Equities, Inc. and Uber Technologies, Inc. Enter Joint Venture Agreement to Acquire and Develop Key Parcels in Mission Bay investment picks
FFO Per Share - Diluted, as Adjusted, for 2Q14 up 11.2% over 2Q13 Core Operations Continue to Deliver Solid Results EPS - Diluted of $0.39 FFO Per Share - Diluted of $1.19 Total Revenues of $176.4 Million NOI of $124.0 Million PASADENA, Calif.
Sign-up for Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2014 Financial and Operating Results investment picks
2014/7/29
VANCOUVER , July 29, 2014 /PRNewswire/ - Alexco Resource Corp.
Sign-up for Alexco Announces C$5 Million Equity Financing investment picks
2014/8/26
Alexco Announces Exercise of Underwriter's Over-Allotment Option Canada NewsWire SOURCE Alexco Resource Corp.
Sign-up for Alexco Announces Exercise of Underwriter's Over-Allotment Option investment picks
2014/8/26
VANCOUVER , Aug.
Sign-up for Alexco Announces Exercise of Underwriter's Over-Allotment Option investment picks
2014/7/30
Alexco Announces Increase to Previously Announced Bought Deal Unit Financing Canada NewsWire /NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / VANCOUVER , July 30, 2014 /CNW/ - Alexco Resource Corp.
Sign-up for Alexco Announces Increase to Previously Announced Bought Deal Unit Financing investment picks
2014/7/30
VANCOUVER , July 30, 2014 /PRNewswire/ - Alexco Resource Corp.
Sign-up for Alexco Announces Increase to Previously Announced Bought Deal Unit Financing investment picks
Alexco Closes Underwriter's Over-Allotment Option Canada NewsWire SOURCE Alexco Resource Corp.
Sign-up for Alexco Closes Underwriter's Over-Allotment Option investment picks
2014/8/28
VANCOUVER , Aug.
Sign-up for Alexco Closes Underwriter's Over-Allotment Option investment picks
2014/8/21
VANCOUVER , Aug.
Sign-up for Alexco Completes C$7 Million Bought Deal Financing investment picks
2014/8/21
Alexco Completes C$7 Million Bought Deal Financing Canada NewsWire SOURCE Alexco Resource Corp.
Sign-up for Alexco Completes C$7 Million Bought Deal Financing investment picks
CINCINNATI , June 23, 2014 /PRNewswire-USNewswire/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) and Cincinnati Children's Hospital Medical Center today announced the establishment of a collaboration and fund for the advancement of research in rare disease.
Sign-up for Alexion and Cincinnati Children's Launch Rare Disease Innovation Fund investment picks
Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) and Cincinnati Children’s Hospital Medical Center today announced the establishment of a collaboration and fund for the advancement of research in rare disease.
Sign-up for Alexion and Cincinnati Children’s Launch Rare Disease Innovation Fund investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the appointments of David R.
Sign-up for Alexion Announces the Appointments of David R. Brennan, M. Michele Burns and Christopher J. Coughlin to Its Board of Directors investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the initiation of dosing in a single, multinational, placebo-controlled clinical trial to evaluate the efficacy and safety of eculizumab (Soliris ® ) for the prevention of delayed graft function (DGF) after kidney transplantation in adult patients who are at increased risk of DGF.
Sign-up for Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation investment picks
Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) today announced that the Company will report its financial results for the second quarter ended June 30, 2014 on Thursday, July 24, 2014 before the US financial markets open.
Sign-up for Alexion Pharmaceuticals to Report Second Quarter 2014 Results on Thursday, July 24, 2014 investment picks
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced financial results for the three and six months ended June 30, 2014.
Sign-up for Alexion Reports Second Quarter 2014 Results investment picks
Alexion Pharmaceuticals (Nasdaq: ALXN) today announced that management will present at two upcoming investor conferences: Robert W.
Sign-up for Alexion to Present at Investor Conferences investment picks
MOUNTAIN VIEW, Calif.
Sign-up for Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences investment picks
First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif.
Sign-up for Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Alexandria Begins 10,000 m Drill Program in Val d'Or to Alexza Pharmaceuticals Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices